Authors

John A Bell

AM, BPharm, FPS, Graduate School of Health, University of Technology Sydney, NSW


Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine

There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19.